ME/CFS remains one of the most invalidated and underdiagnosed diseases in modern medicine. Despite affecting millions worldwide, there is still no FDA-approved diagnostic test. Instead, patients endure years of uncertainty, misdiagnosis, and medical dismissal as they navigate the uncertain journey toward validation and care.
In case you missed it, this video highlights individuals from around the world using their limited energy to complete the sentence “ME/CFS is…” Their voices reveal the harsh realities of living with this disease—the challenges, the losses, and the urgent need for change.
Supporting OMF is critical to accelerating research for ME/CFS and Long COVID around the world. Your contribution directly fuels research that uncovers the underlying causes, develops potential diagnostics, and moves us closer to effective treatments.
Right now, there are only 48 HOURS LEFT to make your gift count even more. During our annual Triple Giving November campaign, all donations are tripled—up to $1 million—through December 2. This is a unique opportunity to multiply your impact and help accelerate research that brings hope to people worldwide.
Thank you so much for your support during our Triple Giving November campaign and beyond. Your generosity makes a real difference for the ME/CFS and Long COVID community globally.
With hope for all,
Team OMF
Donate your appreciated stock directly to OMF and you can receive an immediate income-tax deduction for the fair market value of the securities on the date of transfer (even if you originally paid much less for them).